G33C (p.Gly33Cys) variant of AMH (Anti-Muellerian hormone)
G33C (p.Gly33Cys) in AMH (Anti-Muellerian hormone) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.23 / 1. The record also includes population frequency data and structural context.
G33C (p.Gly33Cys) variant details
- p.Gly33Cys
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.229
- REVEL 0.27
- CADD 13.00
- PolyPhen-2 0.31
- SIFT 0.00
- MutPred 0.71
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available